Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Alzamend Neuro Inc
ALZN
Healthcare
Biotechnology
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic...
cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ALZN)
New Post
View:
Posts & Comments
Threaded Posts
(276)
•••
whytestocks
X
Post by
whytestocks
on Oct 15, 2024 12:16pm
Alzamend Neuro Regains Compliance with Nasdaq Listing Standa
NEWS: $ALZN Alzamend Neuro Regains Compliance with Nasdaq Listing StandardsAlzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 26, 2024 8:05am
New Press Release - Alzamend Neuro Issues Letter to Stockholders
Alzamend recently announced partnership with Massachusetts General Hospital for five phase II clinical trials of AL001, involving healthy human subjects and patients with Alzheimer’s, BD, MDD and PTSDAlzamend has executed an agreement to provide sufficient capital over the next 18 months to...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 20, 2024 10:01am
ALZN.....Now trading at $5
Thanks to all the Chasers & FOMO's.....and you to Shorters ; ) Cheers !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 19, 2024 3:56pm
ALZN.....what a ride today
sub $6 now
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 19, 2024 3:14pm
ALZN....when's the P.O announcement?????
Cheers
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Aug 19, 2024 3:11pm
RE:ALZN ....early a.m runner up on NR this a.m but....
I may have missed the big trade but I ended up being right. Cheers to all the a.m Chasers....now called "Bagholders"
(5)
•••
10QKing
X
Post by
10QKing
on Aug 19, 2024 1:44pm
ALZN Nice NCNA Upgrade out with 150$ price target
NCNA Upgrade out with 150$ price target Currently 4$ Low Float Phase 2 Data due soon https://www.investing.com/news/company-news/nucana-shares-receive-150-stock-pt-at-oppenheimer-on-upbeat-trial
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 19, 2024 9:29am
ALZN ....early a.m runner up on NR this a.m but....
Dumping on Retail traders on the opening bell ....Idare you ; ) sec.gov/Archives/edgar/data/1677077/000121465924012165/z79241424b3.htm
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 4:22am
Alzamend Neuro, Inc. (NASDAQ:ALZN): Promising Alzheimer̵
https://beyondspx.com/2024/08/02/alzamend-neuro-inc-nasdaqalzn-promising-alzheimers-and-neuropsychiatric-therapeutics-pipeline-but-liquidity-concerns-remain/
(15)
•••
HDavis
X
Post by
HDavis
on Nov 24, 2021 10:19pm
ALZN - Wednesday Rundown, Friday Expectations
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 29, 2021 10:31am
ALZN .... Meh
Zero follow through this a.m Taking a "Rain Check" Cya
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 28, 2021 3:30pm
RE:ALZN ....halted on NR....resumed
Recent IPO at $5.00 ...traded up to over $30 There will be some chasers who want their money back
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 28, 2021 3:27pm
ALZN ....halted on NR....resumed
Pounded stock could get some more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages